UK shareholder meetings calendar - next 7 days
20th Feb 2025 14:16
(Alliance News) - Oncimmune Holdings PLC on Monday said its revenue more than doubled in financial 2024, and it expects further growth in financial 2025, with revenue forecast to rise to GBP4 million. Read More
(Alliance News) - The following stocks are the leading risers and fallers on AIM on Friday. Read More
Oncimmune Holdings PLC - Leeds, England-based autoantibody profiling research services to pharmaceutical and biotechnology industry to enable delivery of precision medicine - Reiterates it expects to report revenue of around GBP3 million for the financial year ended August 31, surged from GBP1.2 million a year prior. However, notes that since the end of October, one potential contract was deferred into financial year 2026, and one was removed from its pipeline. Read More
(Alliance News) - Oncimmune Holdings PLC on Thursday highlighted its ability to secure repeat business from "top 10 pharma companies". Read More
Oncimmune Holdings PLC - Leeds, England-based autoantibody profiling research services to pharmaceutical and biotechnology industry to enable delivery of precision medicine - Raises GBP2.2 million from placing of 12.0 million new shares and subscription for 2.3 million more, all at 15 pence. The results of the placing, run as an accelerated bookbuild by brokers Cavendish and Zeus, is in line with plans set out early Friday. Oncimmune also plans a retail share offer of up to 2.0 million shares to raise an additional GBP300,000. Read More
Oncimmune Holdings PLC - Nottingham, England-based autoantibody profiling research services to pharmaceutical and biotechnology industry to enable delivery of precision medicine - Recapitalises two-thirds of its debt and launches a new share offer to raise funds to support recent contract wins and prepare for its "next stage of growth". Read More
(Alliance News) - Oncimmune Holdings PLC said on Monday that it has entered into five new contracts since its last update in May this year, which are set to substantially grow revenue for financial 2025. Read More
(Alliance News) - Oncimmune Holdings PLC announced on Monday that it has won a new contract with a top 10 global pharma company, for a project focused on a rare immune-related disease. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and Friday and not separately reported by Alliance News: Read More
(Alliance News) - The following stocks are the leading risers and fallers on AIM on Friday. Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
Oncimmune Holdings PLC - Nottingham, England-based immunodiagnostics developer - Announces plans to focus on higher value customers, penetrating key accounts, partnering with key technology suppliers and launching new tools. Intends to accelerate new commercial contracts through partnerships with more contract research organisations to expand customer base, leverage auto-antibody analysis capabilities across new areas like companion diagnostics, and augment its commercial team. Also plans to expand its business models "beyond price-per-sample to more strategic partnership models" with upfront project and milestone success fees to better reflect its value. Update follows the disposal of Oncimmune Ltd in May, and the hiring of Martin Gouldstone as chief executive officer and Martin Hudson as finance director in August and September respectively. Company says final results for year ended August 31 will be released in due course. Read More
(Alliance News) - Oncimmune Holdings PLC on Wednesday said it appointed Martin Gouldstone as its new chief executive, replacing Adam Hill who stepped down following the divestment of Oncimmune Ltd. Read More
(Alliance News) - Oncimmune Holdings PLC on Friday said its chief executive officer will step down, as it unveiled a new plan for delivering refocused growth. Read More
(Alliance News) - Oncimmune Holdings PLC on Wednesday said revenue was down in the first half of its financial year due to delivery delays, but its loss narrowed. Read More